# A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients

> **NCT00453778** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 14 (—)

## Conditions studied

- Asthma
- Mild Asthma

## Interventions

- **DRUG:** FLIXOTIDE Diskus 500 mcg (Fluticasone Propionate)

## Key facts

- **NCT ID:** NCT00453778
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11
- **Primary completion:** 2004-05
- **Final completion:** 2004-05
- **Target enrollment:** 14 (—)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00453778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00453778, "A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00453778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*